Primary Record
BIIB021
- In stock
- 2,509 g
- Purity
- 98.7 %
- CAS
- 848695-25-0
Compound Identifiers & Properties
- CAS
- 848695-25-0
- PubChem CID
- 16736529
- SMILES
- CC1=CN=C(C(=C1OC)C)CN2C=NC3=C2N=C(N=C3Cl)N
- Canonical SMILES
- COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc32)c1C
Names & Synonyms
- BIIB021
- 848695-25-0
- BIIB-021
- BIIB 021
- CNF2024
- 6-chloro-9-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-9H-purin-2-amine
- 3qdd
- EC-82, Conforma
- EC-145, Conforma
- CNF-2024
- UNII-851B9FQ7Q0
- C14H15ClN6O
- RefChem:119789
- BIIB021, Free Base
- 851B9FQ7Q0
- D05HWN
- CHEMBL467399
- MFCD15528939
- cc-544
- CHEBI:90687
- CNF 2024
- MLS006011080
- QULDDKSCVCJTPV-UHFFFAOYSA-N
- GTPL9258
- orb1305792
- SCHEMBL1791028
- BIIB 021 [WHO-DD]
- BIIB021,CNF2024
- BIIB021/CNF2024
- CNF2024,BIIB021
- SCHEMBL29351570
- SCHEMBL29394202
- SCHEMBL29409214
- BDBM20800
- CTK8C3937
- 848695-25-0 (free base)
- AOB4502
- EX-A681
- QCR-185
- BIIB021; CNF2024
- CF1983
- CNF2024, BIIB021
- BCPP000335
- DTXSID601025952
- EC-78
- EC-89
- GLXC-03674
- HMS3654G16
- BCP02111
- CNF-3647
- KS-00001CQ1
- YIB69525
- 2-amino-6-halopurine analogue, 20
- BIIB021(CNF2024)?
- ABP000837
- ANW-70835
- EC-129
- EC-137
- EC-138
- EC-141
- EC-144
- EC-146
- EC-147
- EC-151
- NSC773265
- s1175
- ZINC14974583
- AKOS015969048
- ACN-025760
- BCP9000411
- CCG-264848
- CS-0168
- DB12359
- NSC-773265
- RL05218
- SB16641
- Hsp90 inhibitor (cancer), Biogen Idec
- NCGC00247877-01
- 4CA-0277
- AC-32860
- AJ-65528
- AK104952
- AS-55914
- BC660077
- HY-10212
- SMR004702868
- AB0008087
- TC-159580
- (6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9h-purin-2-yl)amine
- A4058
- FT-0696777
- NS00071234
- ST24045314
- SW220186-1
- X7555
- 6-chloro-9-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]purin-2-amine
- J3.159.783H
- A10143
- A20586
- F14744
- Synthetic Hsp90 inhibitors (cancer), Conforma
- W-5597
- 6-Chloro-9-[(4-Methoxy-3,5-Dimethylpyridin-2-Yl)methyl]-9h-Purin-2-Amine
- 9H-purin-2-amine, 6-chloro-9-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)-
- Hsp90 inhibitors (synthetic, cancer), Conforma
- BRD-K51967704-001-01-0
- BRD-K51967704-001-03-6
- BRD-K51967704-001-04-4
- Q27075249
- [6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-yl]amine
- 6-chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine
- 6-Chloro-9-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-9h-purin-2-amine
- 6-chloro-9-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)-9h-purin-2-amine
- 6-chloro-9-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)purin-2-amine
- 6-Chloro-9-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]-9H-purine-2-amine
- 6-chloro-9-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]purin-2-amine
- 94M
- (6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9h-purin-2-yl)amin
- 9H-Purin-2-amine, 6-chloro-9-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-